Too short → bleeding, hematoma. Too long → occlusion, thrombosis, patient discomfort. Evidence shows 2 hours is the optimal window for radial hemostasis, and femoral compression can be drastically shortened when focal pressure preserves perfusion. MeterOmega’s Ball & Bowl technology achieves the sweet spot — faster, safer, more comfortable.

Hemostasis duration is a double‑edged sword. Prolonged compression increases the risk of radial artery occlusion (RAO), deep vein thrombosis, and patient discomfort. Shortened compression, however, raises the risk of access site hematoma and rebleeding. The optimal window is narrow and device‑dependent.

Maqsood et al. (2023) – Mixed Treatment Meta‑Analysis of 10 RCTs (n=4,911): When compared with the 2‑hour reference, shorter duration (<90 min) significantly increased hematoma risk (OR 3.61), while longer duration (2–4 hours) trended toward higher RAO. Conclusion: 2 hours offers the best balance for efficacy (RAO prevention) and safety (hematoma/rebleeding).

Yet most traditional compression devices cannot achieve this ideal window. Flat plates and soft balloons require extended compression because they fail to maintain continuous, targeted pressure without compromising distal flow.

Conventional TR bands and screw‑type devices often require 4–6 hours due to diffuse compression and risk of rebleeding. Crystal‑Hemostop™’s focal ball compression maintains antegrade flow, allowing safe deflation at 2 hours without compromising hemostasis.

Traditional femoral hemostasis protocols dictate 1 hour of bed rest per French sheath size (e.g., 6F → 6 hours). This originates from manual compression techniques that rely on broad pressure and prolonged immobility2. However, studies show that effective focal compression can achieve hemostasis in 20–30 minutes, with total bed rest reduced to 2–4 hours.

Kim et al. (2014): In patients undergoing femoral angiography, the mean time to hemostasis with a compression device (focal pressure) was 20.37 ± 8.23 minutes — dramatically shorter than manual compression (29.30 min) and with no increase in major complications when combined with short manual hold.

FEMO‑SUPERBOWL™ takes this principle further. The rigid spherical bowl transmits force through subcutaneous tissue directly to the femoral arteriotomy, eliminating the need for circumferential thigh compression. The result: hemostasis in under 30 minutes, ambulation in 2–4 hours, and no foreign body left behind.

 • Reduced RAO: Focal compression preserves flow, lowering occlusion rates to <2% in clinical series.
 • Less Pain & Discomfort: No tourniquet effect; patients report minimal to no discomfort during compression.
 • Earlier Ambulation: Radial patients can mobilize immediately; femoral patients walk within 2–4 hours vs. 6–12 hours with manual protocols.
 • Lower Complication Costs: Fewer rebleeds, fewer hematomas, and no device‑related infections translate to reduced length of stay and resource utilization.

Economic consideration: A 2‑hour vs. 6‑hour compression time reduces nursing monitoring time, frees catheterization lab beds, and improves patient throughput — without increasing adverse events.

FEMO‑SUPERBOWL™ takes this principle further. The rigid spherical bowl transmits force through subcutaneous tissue directly to the femoral arteriotomy, eliminating the need for circumferential thigh compression. The result: hemostasis in under 30 minutes, ambulation in 2–4 hours, and no foreign body left behind.